Catalyst Wire Dossier Catalyst Wire Dossier

Hydrocortisone ophthalmic ointment 0.5%

hydrocortisone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydrocortisone ophthalmic ointment 0.5%, covering 2017-08-18 to 2017-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis [Phase 2]

See pricing